Exploring a Tumor-Intrinsic PD-L1 Signal with Proximity-Dependent Biotin Identification in Lung Cancer Cells

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Immune checkpoint inhibitors targeting the programmed cell death-ligand 1 (PD-L1) and programmed cell death 1 (PD-1) interaction yield durable responses in advanced cancers.
• The mechanisms by which PD-L1 engagement triggers tumor-intrinsic signaling remain largely unknown.

Purpose of the Study:

• To identify novel protein substrates that mediate tumor-intrinsic PD-L1 signaling.
• To explore the role of PD-L1 in cancer cell-autonomous pathways.

Main Methods:

• Utilized a proximity-dependent biotin identification (BioID) assay by fusing PD-L1 to a promiscuous biotin ligase (BirA*) in lung adenocarcinoma A549 cells.
• Employed streptavidin affinity capture followed by mass spectrometry to identify PD-L1 interacting proteins.

Main Results:

• Identified 57 candidate proteins interacting with PD-L1, including 18 proteins whose interaction was dependent on PD-L1/PD-1 engagement.
• Discovered that 9 of the identified candidates are involved in the epidermal growth factor receptor (EGFR) signaling pathway.

Conclusions:

• This research provides a novel set of potential tumor-intrinsic PD-L1 signaling effectors.
• The identified proteins, particularly those in the EGFR pathway, may represent new therapeutic targets for lung cancer.